Johnson & Johnson (JNJ)
$63.30
0.12 (+0.19%)
| CAPS Rating |
|
|---|---|
| Open | $63.38 |
| Previous Close | $63.18 |
| Daily Range | $62.93 - $63.44 |
| 52-Week Range | $46.25 - $63.10 |
| Market Cap | $174.65B |
| P/E Ratio | 13.57 |
| Dividend (Yield) | 1.96 (3.10%) |
| Volume | 7,175,393 |
| Average Daily Volume | 13,377,000 |
JNJ
VS S&P 500 (SPY)
How do you think JNJ will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
JNJ Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
JNJ News and Commentary
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- Commentary around Pharma – Blog at The Motley Fool
- A Schizophrenic Move by Merck? – The Motley Fool
- 5-Star Stocks Poised to Pop: Hawkins – The Motley Fool
- 4-Star Stocks Poised to Pop: National Presto – The Motley Fool
- Do Good Without Being a Corporate Hotshot – The Motley Fool
- 10 Terrific Dividend-Paying Stocks – SmartMoney
- 52-Week Highs! What's Going On? – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- 5-Star Stocks Poised to Pop: Exelon – The Motley Fool
- How I'm Grabbing 20% Dividend Yields – The Motley Fool
- Buy & Sell List From Betapeg – Blog at The Motley Fool
- 5-Star Stocks Poised to Pop: PetMed Express – The Motley Fool
- 1-Star Stocks Poised to Plunge: salesforce.com? – The Motley Fool
- The Highest Possible Returns. Period. – The Motley Fool
- MARKET SNAPSHOT: Investors May Turn Defensive As Fizz Leaves Stocks – SmartMoney
- Who's Paying for Health-Care Reform? – The Motley Fool
- An Open Letter to the Federal Reserve – The Motley Fool
- Now Is the Time to Buy Risk – The Motley Fool
- Fusion IP Signs Licensing Deal With Orthopedic Firm – SmartMoney
RSS Headlines
Fool UK
